166 related articles for article (PubMed ID: 22955913)
1. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.
Tripodo C; Sangaletti S; Guarnotta C; Piccaluga PP; Cacciatore M; Giuliano M; Franco G; Chiodoni C; Sciandra M; Miotti S; Calvaruso G; Carè A; Florena AM; Scotlandi K; Orazi A; Pileri SA; Colombo MP
Blood; 2012 Oct; 120(17):3541-54. PubMed ID: 22955913
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
[TBL] [Abstract][Full Text] [Related]
3. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
[TBL] [Abstract][Full Text] [Related]
4. Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.
Sangaletti S; Tripodo C; Portararo P; Dugo M; Vitali C; Botti L; Guarnotta C; Cappetti B; Gulino A; Torselli I; Casalini P; Chiodoni C; Colombo MP
Oncoimmunology; 2014; 3():e28989. PubMed ID: 25083326
[TBL] [Abstract][Full Text] [Related]
5. SPARC deficiency affects bone marrow stromal function, resulting in impaired B lymphopoiesis.
Luo Z; Zhou Y; Luo P; Zhao Q; Xiao N; Yu Y; Yan Q; Lu G; Cheng L
J Leukoc Biol; 2014 Jul; 96(1):73-82. PubMed ID: 24598056
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.
Schepers K; Pietras EM; Reynaud D; Flach J; Binnewies M; Garg T; Wagers AJ; Hsiao EC; Passegué E
Cell Stem Cell; 2013 Sep; 13(3):285-99. PubMed ID: 23850243
[TBL] [Abstract][Full Text] [Related]
7. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
Ozono Y; Shide K; Kameda T; Kamiunten A; Tahira Y; Sekine M; Akizuki K; Nakamura K; Iwakiri H; Sueta M; Hidaka T; Kubuki Y; Yamamoto S; Hasuike S; Sawaguchi A; Nagata K; Shimoda K
Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
Selicean SE; Tomuleasa C; Grewal R; Almeida-Porada G; Berindan-Neagoe I
Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
[TBL] [Abstract][Full Text] [Related]
12. SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.
Riley HJ; Kelly RR; Van Laer AO; Neff LS; Dasgupta S; Baicu CF; McDonald LT; LaRue AC; Zile MR; Bradshaw AD
Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H604-H612. PubMed ID: 33306449
[TBL] [Abstract][Full Text] [Related]
13. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
Gleitz HF; Kramann R; Schneider RK
J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
[TBL] [Abstract][Full Text] [Related]
14. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of myelofibrosis with myeloid metaplasia.
Tefferi A
J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
[TBL] [Abstract][Full Text] [Related]
16. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.
Tripodo C; Di Bernardo A; Ternullo MP; Guarnotta C; Porcasi R; Ingrao S; Gianelli U; Boveri E; Iannitto E; Franco G; Florena AM
Haematologica; 2009 Jan; 94(1):127-30. PubMed ID: 19029148
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis.
Martinaud C; Desterke C; Konopacki J; Vannucchi AM; Pieri L; Guglielmelli P; Dupriez B; Ianotto JC; Boutin L; Lataillade JJ; Le Bousse-Kerdilès MC
Genom Data; 2015 Sep; 5():1-2. PubMed ID: 26484208
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.
Sangaletti S; Stoppacciaro A; Guiducci C; Torrisi MR; Colombo MP
J Exp Med; 2003 Nov; 198(10):1475-85. PubMed ID: 14610043
[TBL] [Abstract][Full Text] [Related]
19. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
[TBL] [Abstract][Full Text] [Related]
20. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]